Analysis of the US and European Diabetes Diagnostics Market
Analysis of the US and European Diabetes Diagnostics Market
Constricting Reimbursement Policies Restrain Market Growth
01-Jul-2015
North America
$6,950.00
Special Price $5,212.50 save 25 %
Description
The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-invasive technologies is disrupting this market space as it reduces patient pain points while providing accurate and sensitive results. Due to more hospital-centric care in the EU region, the POCT segment here experiences stronger growth than in the United States. POCT has the potential to grow the fastest due to its efficient, cost-effective solution and increasing adoption by physicians.
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Key Findings
Scope and Segmentation
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
- HemoCue (US and Europe)
- NovioSense (US)
- Miraculins (US)
3 Big Predictions
Introduction to Diabetes
Market Overview
Market Segmentation
Segment Life Cycle Analysis
Competitive Segment Analysis
Defining Healthcare Trends in the Future
Diabetes Diagnostics Market—Competitive Landscape
New Market Opportunities
Competitive Analysis
Market Engineering Measurements
Revenue Forecast
Segment Overview
Revenue Forecast by Segment
Market Drivers
Market Restraints
Market Engineering Measurements
US Revenue Forecast
Segment Overview
Revenue Forecast by Segment
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Segment
Market Share Analysis
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Segment
Market Share Analysis
Market Engineering Measurements
Revenue Forecast
Market Share Analysis
Lab-based Testing Trends
Comparison of Lab-based Tests
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Region
Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast by Segment
Market Share Analysis
Market Engineering Measurements
Revenue Forecast
Market Share Analysis
Lab-based Testing Trends
Comparison of Lab-based Tests
Regional Overview
Revenue Forecast—The United Kingdom
UK Regulations and Reimbursements
Revenue Forecast by Segment—The United Kingdom
Market Impact of Top 10 Trends
Revenue Forecast—Germany
Germany Reimbursements and Regulations
Revenue Forecast by Segment—Germany
Revenue Forecast—France
France Reimbursements and Regulations
Revenue Forecast by Segment—France
Revenue Forecast—Italy
Italy Reimbursements and Regulations
Revenue Forecast by Segment—Italy
Revenue Forecast—Spain
Spain Reimbursements and Regulations
Revenue Forecast by Segment—Spain
Revenue Forecast—Benelux (Belgium, the Netherlands, Luxembourg)
Benelux Reimbursements and Regulations
Revenue Forecast by Segment—Benelux
Revenue Forecast—Scandinavia
Scandinavia Reimbursements and Regulations
Revenue Forecast by Segment—Scandinavia
HemoCue
NovioSense
Miraculins
3 Big Predictions
Market Engineering Methodology
- 1. Total Diabetes Diagnostics Market: Competitive Segment Analysis, US and Europe, 2014
- 2. Total Diabetes Diagnostics Market: Market Outlook, US and Europe, 2014 and 2024
- 3. Total Diabetes Diagnostics Market: Game-changing Strategies, US and Europe, 2014
- 4. Total Diabetes Diagnostics Market: Top Product Analysis, US and Europe, 2014
- 5. Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
- 6. Diabetes Diagnostics Market: Key Market Drivers, US, 2015–2020
- 7. Diabetes Diagnostics Market: Key Market Restraints, US, 2015–2020
- 8. Diabetes Diagnostics Market: Market Engineering Measurements, US, 2014
- 9. SMBG Segment: Market Engineering Measurements, US, 2014
- 10. SMBG Segment: Market Positions of the Leading Participants, US, 2014
- 11. POCT Segment: Market Engineering Measurements, US, 2014
- 12. Lab-based HbA1c Testing Segment: Market Engineering Measurements, US, 2014
- 13. Diabetes Diagnostics Market: Market Engineering Measurements, Europe, 2014
- 14. SMBG Segment: Market Engineering Measurements, Europe, 2014
- 15. POCT Segment: Market Engineering Measurements, Europe, 2014
- 16. Lab-based HbA1c Testing Segment: Market Engineering Measurements, Europe, 2014
- 1. Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
- 2. Total Diabetes Diagnostics Market: Percent Prevalence of Diabetes, Global, 2014
- 3. Total Diabetes Diagnostics Market: Market Segmentation, US and Europe, 2014
- 4. Total Diabetes Diagnostics Market: Segment Life Cycle Analysis, US and Europe, 2014
- 5. Total Diabetes Diagnostics Market: Percent Revenue Breakdown, US and Europe, 2014
- 6. Total Diabetes Diagnostics Market: Competitive Landscape, US and Europe, 2014
- 7. Total Diabetes Diagnostics Market: Revenue Forecast, US and Europe, 2011–2020
- 8. Total Diabetes Diagnostics Market by Segment: Percent Sales Breakdown, US and Europe, 2014
- 9. Total Diabetes Diagnostics Market: Percent Sales Breakdown, US and Europe, 2020
- 10. Total Diabetes Diagnostics Market: Revenue Forecast by Segment, US and Europe, 2011–2020
- 11. Diabetes Diagnostics Market: Revenue Forecast, US, 2011–2020
- 12. Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2014
- 13. Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2020
- 14. Diabetes Diagnostics Market: Revenue Forecast by Segment, US, 2011–2020
- 15. SMBG Segment: Revenue Forecast, US, 2011–2020
- 16. SMBG Segment: Revenue Forecast by Sub-Segment, US, 2011–2020
- 17. SMBG Segment: Percent Revenue Breakdown, US, 2014
- 18. POCT Segment: Revenue Forecast, US, 2011–2020
- 19. POCT Segment: Revenue Forecast by Sub-Segment, US, 2011–2020
- 20. POCT Segment: Percent Revenue Breakdown, US, 2014
- 21. Lab-based HbA1c Testing Segment: Revenue Forecast, US, 2011–2020
- 22. Lab-based Testing Segment: Percent Revenue Breakdown, US, 2014
- 23. Diabetes Diagnostics Market: Trends of Lab-based Tests, US, 2014
- 24. FPG Testing: Market Potential, US, 2014
- 25. OGTT Testing: Market Potential, US, 2014
- 26. HbA1c Testing: Market Potential, US, 2014
- 27. Microalbumin: Market Potential, US, 2014
- 28. Diabetes Diagnostics Market: Revenue Forecast, Europe, 2011–2020
- 29. Diabetes Diagnostics Market: Revenue Forecast by Region, Europe, 2011–2020
- 30. Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2014
- 31. Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2020
- 32. SMBG Segment: Revenue Forecast, Europe, 2011–2020
- 33. SMBG Segment: Revenue Forecast by Segment, Europe, 2011–2020
- 34. SMBG Segment: Percent Revenue Breakdown, Europe, 2014
- 35. POCT Segment: Revenue Forecast, Europe, 2011–2020
- 36. POCT Segment: Revenue Forecast by Segment, Europe, 2011–2020
- 37. POCT Segment: Percent Revenue Breakdown, Europe, 2014
- 38. Lab-based HbA1c Testing Segment: Revenue Forecast, Europe, 2011–2020
- 39. Lab-based Testing Segment: Percent Revenue Breakdown, Europe, 2014
- 40. Diabetes Diagnostics Market: Trends of Lab-based Tests, Europe, 2014
- 41. FPG Testing: Market Potential, Europe, 2014
- 42. OGTT Testing: Market Potential, Europe, 2014
- 43. HbA1c Testing: Market Potential, Europe, 2014
- 44. Microalbumin: Market Potential, Europe, 2014
- 45. Diabetes Diagnostics Market: Percent Sales Breakdown by Region, Europe, 2014
- 46. Diabetes Diagnostics Market: Revenue Forecast, UK, 2011–2020
- 47. Diabetes Diagnostics Market: Demographic Information, UK, 2014
- 48. Diabetes Diagnostics Market: Revenue Forecast by Segment, UK, 2011–2020
- 49. Diabetes Diagnostics Market: Impact of Top 10 Trends, UK, 2014
- 50. Diabetes Diagnostics Market: Revenue Forecast, Germany, 2011–2020
- 51. Diabetes Diagnostics Market: Demographic Information, Germany, 2014
- 52. Diabetes Diagnostics Market: Revenue Forecast by Segment, Germany, 2011–2020
- 53. Diabetes Diagnostics Market: Impact of Top 10 Trends, Germany, 2014
- 54. Diabetes Diagnostics Market: Revenue Forecast, France, 2011–2020
- 55. Diabetes Diagnostics Market: Demographic Information, France, 2014
- 56. Diabetes Diagnostics Market: Revenue Forecast by Segment, France, 2011–2020
- 57. Diabetes Diagnostics Market: Impact of Top 10 Trends, France, 2014
- 58. Diabetes Diagnostics Market: Revenue Forecast, Italy, 2011–2020
- 59. Diabetes Diagnostics Market: Demographic Information, Italy, 2014
- 60. Diabetes Diagnostics Market: Revenue Forecast by Segment, Italy, 2011–2020
- 61. Diabetes Diagnostics Market: Impact of Top 10 Trends, Italy, 2014
- 62. Diabetes Diagnostics Market: Revenue Forecast, Spain, 2011–2020
- 63. Diabetes Diagnostics Market: Demographic Information, Spain, 2014
- 64. Diabetes Diagnostics Market: Revenue Forecast by Segment, Spain, 2011–2020
- 65. Diabetes Diagnostics Market: Impact of Top 10 Trends, Spain, 2014
- 66. Diabetes Diagnostics Market: Revenue Forecast, Benelux, 2011–2020
- 67. Diabetes Diagnostics Market: Demographic Information, Belgium, 2014
- 68. Diabetes Diagnostics Market: Demographic Information, the Netherlands, 2014
- 69. Diabetes Diagnostics Market: Revenue Forecast by Segment, Benelux, 2011–2020
- 70. Diabetes Diagnostics Market: Revenue Forecast, Scandinavia, 2011–2020
- 71. Diabetes Diagnostics Market: Demographic Information, Scandinavia, 2014
- 72. Diabetes Diagnostics Market: Revenue Forecast by Segment, Scandinavia, 2011–2020
- 73. Diabetes Diagnostics Market: Impact of Top 10 Trends, Benelux and Scandinavia, 2014
No Index | No |
---|---|
Podcast | No |
Table of Contents | | Executive Summary~ || Key Findings~ || Scope and Segmentation~ || Market Engineering Measurements~ || CEO’s Perspective~ || Key Companies to Watch~ ||| HemoCue (US and Europe)~ ||| NovioSense (US)~ ||| Miraculins (US)~ || 3 Big Predictions~ | Market Overview~ || Introduction to Diabetes~ || Market Overview~ || Market Segmentation~ || Segment Life Cycle Analysis~ || Competitive Segment Analysis~ || Defining Healthcare Trends in the Future~ | Competitive Playbook~ || Diabetes Diagnostics Market—Competitive Landscape~ || New Market Opportunities~ || Competitive Analysis~ | Total Market Analysis~ || Market Engineering Measurements~ || Revenue Forecast~ || Segment Overview~ || Revenue Forecast by Segment~ | US Analysis~ || Market Drivers~ ||| Switching to a value-based healthcare practice~ ||| Growing healthcare expenditure~ ||| Increasing push for decentralized testing~ ||| Growing trend of integrating technology with mobile devices~ ||| Increase in consumer-specific products~ || Market Restraints~ ||| Strained laboratory budgets~ ||| Competitive pricing~ ||| Tougher US regulatory environment~ || Market Engineering Measurements~ || US Revenue Forecast~ || Segment Overview~ || Revenue Forecast by Segment~ | US SMBG Segment~ || Market Engineering Measurements~ || Revenue Forecast~ || Revenue Forecast by Segment~ || Market Share Analysis~ | US POCT Segment~ || Market Engineering Measurements~ || Revenue Forecast~ || Revenue Forecast by Segment~ || Market Share Analysis~ | US Lab-based Testing Segment~ || Market Engineering Measurements~ || Revenue Forecast~ || Market Share Analysis~ || Lab-based Testing Trends~ || Comparison of Lab-based Tests~ | Europe Analysis~ || Market Engineering Measurements~ || Revenue Forecast~ || Revenue Forecast by Region~ || Segment Overview~ | Europe SMBG Segment~ || Market Engineering Measurements~ || Revenue Forecast~ || Revenue Forecast by Segment~ || Market Share Analysis~ | Europe POCT Segment~ | Europe Lab-based Testing Segment~ || Market Engineering Measurements~ || Revenue Forecast~ || Market Share Analysis~ || Lab-based Testing Trends~ || Comparison of Lab-based Tests~ | Europe—Regional Analysis~ || Regional Overview~ || Revenue Forecast—The United Kingdom~ || UK Regulations and Reimbursements~ || Revenue Forecast by Segment—The United Kingdom~ || Market Impact of Top 10 Trends~ || Revenue Forecast—Germany~ || Germany Reimbursements and Regulations~ || Revenue Forecast by Segment—Germany~ || Revenue Forecast—France~ || France Reimbursements and Regulations~ || Revenue Forecast by Segment—France~ || Revenue Forecast—Italy~ || Italy Reimbursements and Regulations~ || Revenue Forecast by Segment—Italy~ || Revenue Forecast—Spain~ || Spain Reimbursements and Regulations~ || Revenue Forecast by Segment—Spain~ || Revenue Forecast—Benelux (Belgium, the Netherlands, Luxembourg)~ || Benelux Reimbursements and Regulations~ || Revenue Forecast by Segment—Benelux~ || Revenue Forecast—Scandinavia~ || Scandinavia Reimbursements and Regulations~ || Revenue Forecast by Segment—Scandinavia~ | Key Companies to Watch~ || HemoCue~ || NovioSense~ || Miraculins~ | The Last Word~ || 3 Big Predictions~ | Appendix~ || Market Engineering Methodology~ |
List of Charts and Figures | 1. Total Diabetes Diagnostics Market: Competitive Segment Analysis, US and Europe, 2014~ 2. Total Diabetes Diagnostics Market: Market Outlook, US and Europe, 2014 and 2024~ 3. Total Diabetes Diagnostics Market: Game-changing Strategies, US and Europe, 2014~ 4. Total Diabetes Diagnostics Market: Top Product Analysis, US and Europe, 2014~ 5. Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014~ 6. Diabetes Diagnostics Market: Key Market Drivers, US, 2015–2020~ 7. Diabetes Diagnostics Market: Key Market Restraints, US, 2015–2020~ 8. Diabetes Diagnostics Market: Market Engineering Measurements, US, 2014~ 9. SMBG Segment: Market Engineering Measurements, US, 2014~ 10. SMBG Segment: Market Positions of the Leading Participants, US, 2014~ 11. POCT Segment: Market Engineering Measurements, US, 2014~ 12. Lab-based HbA1c Testing Segment: Market Engineering Measurements, US, 2014~ 13. Diabetes Diagnostics Market: Market Engineering Measurements, Europe, 2014~ 14. SMBG Segment: Market Engineering Measurements, Europe, 2014~ 15. POCT Segment: Market Engineering Measurements, Europe, 2014~ 16. Lab-based HbA1c Testing Segment: Market Engineering Measurements, Europe, 2014~| 1. Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014~ 2. Total Diabetes Diagnostics Market: Percent Prevalence of Diabetes, Global, 2014~ 3. Total Diabetes Diagnostics Market: Market Segmentation, US and Europe, 2014~ 4. Total Diabetes Diagnostics Market: Segment Life Cycle Analysis, US and Europe, 2014~ 5. Total Diabetes Diagnostics Market: Percent Revenue Breakdown, US and Europe, 2014~ 6. Total Diabetes Diagnostics Market: Competitive Landscape, US and Europe, 2014~ 7. Total Diabetes Diagnostics Market: Revenue Forecast, US and Europe, 2011–2020~ 8. Total Diabetes Diagnostics Market by Segment: Percent Sales Breakdown, US and Europe, 2014~ 9. Total Diabetes Diagnostics Market: Percent Sales Breakdown, US and Europe, 2020~ 10. Total Diabetes Diagnostics Market: Revenue Forecast by Segment, US and Europe, 2011–2020~ 11. Diabetes Diagnostics Market: Revenue Forecast, US, 2011–2020~ 12. Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2014~ 13. Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2020~ 14. Diabetes Diagnostics Market: Revenue Forecast by Segment, US, 2011–2020~ 15. SMBG Segment: Revenue Forecast, US, 2011–2020~ 16. SMBG Segment: Revenue Forecast by Sub-Segment, US, 2011–2020~ 17. SMBG Segment: Percent Revenue Breakdown, US, 2014~ 18. POCT Segment: Revenue Forecast, US, 2011–2020~ 19. POCT Segment: Revenue Forecast by Sub-Segment, US, 2011–2020~ 20. POCT Segment: Percent Revenue Breakdown, US, 2014~ 21. Lab-based HbA1c Testing Segment: Revenue Forecast, US, 2011–2020~ 22. Lab-based Testing Segment: Percent Revenue Breakdown, US, 2014~ 23. Diabetes Diagnostics Market: Trends of Lab-based Tests, US, 2014~ 24. FPG Testing: Market Potential, US, 2014~ 25. OGTT Testing: Market Potential, US, 2014~ 26. HbA1c Testing: Market Potential, US, 2014~ 27. Microalbumin: Market Potential, US, 2014~ 28. Diabetes Diagnostics Market: Revenue Forecast, Europe, 2011–2020~ 29. Diabetes Diagnostics Market: Revenue Forecast by Region, Europe, 2011–2020~ 30. Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2014~ 31. Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2020~ 32. SMBG Segment: Revenue Forecast, Europe, 2011–2020~ 33. SMBG Segment: Revenue Forecast by Segment, Europe, 2011–2020~ 34. SMBG Segment: Percent Revenue Breakdown, Europe, 2014~ 35. POCT Segment: Revenue Forecast, Europe, 2011–2020~ 36. POCT Segment: Revenue Forecast by Segment, Europe, 2011–2020~ 37. POCT Segment: Percent Revenue Breakdown, Europe, 2014~ 38. Lab-based HbA1c Testing Segment: Revenue Forecast, Europe, 2011–2020~ 39. Lab-based Testing Segment: Percent Revenue Breakdown, Europe, 2014~ 40. Diabetes Diagnostics Market: Trends of Lab-based Tests, Europe, 2014~ 41. FPG Testing: Market Potential, Europe, 2014~ 42. OGTT Testing: Market Potential, Europe, 2014~ 43. HbA1c Testing: Market Potential, Europe, 2014~ 44. Microalbumin: Market Potential, Europe, 2014~ 45. Diabetes Diagnostics Market: Percent Sales Breakdown by Region, Europe, 2014~ 46. Diabetes Diagnostics Market: Revenue Forecast, UK, 2011–2020~ 47. Diabetes Diagnostics Market: Demographic Information, UK, 2014~ 48. Diabetes Diagnostics Market: Revenue Forecast by Segment, UK, 2011–2020~ 49. Diabetes Diagnostics Market: Impact of Top 10 Trends, UK, 2014 ~ 50. Diabetes Diagnostics Market: Revenue Forecast, Germany, 2011–2020~ 51. Diabetes Diagnostics Market: Demographic Information, Germany, 2014~ 52. Diabetes Diagnostics Market: Revenue Forecast by Segment, Germany, 2011–2020~ 53. Diabetes Diagnostics Market: Impact of Top 10 Trends, Germany, 2014 ~ 54. Diabetes Diagnostics Market: Revenue Forecast, France, 2011–2020~ 55. Diabetes Diagnostics Market: Demographic Information, France, 2014~ 56. Diabetes Diagnostics Market: Revenue Forecast by Segment, France, 2011–2020~ 57. Diabetes Diagnostics Market: Impact of Top 10 Trends, France, 2014 ~ 58. Diabetes Diagnostics Market: Revenue Forecast, Italy, 2011–2020~ 59. Diabetes Diagnostics Market: Demographic Information, Italy, 2014~ 60. Diabetes Diagnostics Market: Revenue Forecast by Segment, Italy, 2011–2020~ 61. Diabetes Diagnostics Market: Impact of Top 10 Trends, Italy, 2014 ~ 62. Diabetes Diagnostics Market: Revenue Forecast, Spain, 2011–2020~ 63. Diabetes Diagnostics Market: Demographic Information, Spain, 2014~ 64. Diabetes Diagnostics Market: Revenue Forecast by Segment, Spain, 2011–2020~ 65. Diabetes Diagnostics Market: Impact of Top 10 Trends, Spain, 2014 ~ 66. Diabetes Diagnostics Market: Revenue Forecast, Benelux, 2011–2020~ 67. Diabetes Diagnostics Market: Demographic Information, Belgium, 2014~ 68. Diabetes Diagnostics Market: Demographic Information, the Netherlands, 2014~ 69. Diabetes Diagnostics Market: Revenue Forecast by Segment, Benelux, 2011–2020~ 70. Diabetes Diagnostics Market: Revenue Forecast, Scandinavia, 2011–2020~ 71. Diabetes Diagnostics Market: Demographic Information, Scandinavia, 2014~ 72. Diabetes Diagnostics Market: Revenue Forecast by Segment, Scandinavia, 2011–2020~ 73. Diabetes Diagnostics Market: Impact of Top 10 Trends, Benelux and Scandinavia, 2014~ |
Author | Aish Vivekanadan |
WIP Number | NF12-01-00-00-00 |
Is Prebook | No |